CASE CLOSED … what really happened in the 2001 anthrax attacks?

* followup with Senator Grassley’s office regarding FBI answers to the Senator’s September 2008 questions about their investigation of the 2001 anthrax attacks

Posted by DXer on May 30, 2009

LMW COMMENT …  

see previous post … * the (apparent) refusal of the FBI to answer Sen. Grassley’s September 2008 questions raises further suspicions of a continuing FBI cover-up of its failed anthrax investigation

******************************************

On Friday May 30, I again called Senator Grassley’s DC office seeking answers regarding any FBI response to  the Senator’s September 2008 questions directed to FBI Director Meuller.

Senator Charles Grassley (R-Iowa)

Senator Charles Grassley (R-Iowa)

 

I was told to contact Brian Downey on the Senate Finance Committee which I was told has oversight responsibility on this issue. I asked if I could send an email to Mr. Downey and was very graciously told by the person in Senator Grassley’s office that she could not give me Mr. Downey’s email address but if I sent an email to her, she would forward it to Mr. Downey.

I sent the following email on Friday afternoon …

Thank you for trying to help me reach Brian Downey.

Here are my questions for him …

Last September, Senator Grassley sent a letter to the then Attorney General Michael Mukasey and FBI Director Robert Mueller, asking 18 excellent questions about the FBI’s investigation of the anthrax case and the FBI’s determination that USAMRIID scientist Dr. Bruce Ivins was the sole perpetrator of the 2001 anthrax attacks. 

Eight months have passed.

has the FBI responded to the Senator’s questions? 

if yes, when did they respond?

if yes, may I have a copy of the FBI’s answers? 

if no, what is the Senator doing about the FBI’s unwillingness to answer?

 

 

3 Responses to “* followup with Senator Grassley’s office regarding FBI answers to the Senator’s September 2008 questions about their investigation of the 2001 anthrax attacks”

  1. DXer said

    Grassley and his office does great work. When he sees a conflict of interest, he is willing to call industry on the issue even if the practice seems well-entrenched.

    Given that Bruce Ivins gave a recently minted PhD microbiology (Cairo Medical 1994) virulent Ames in connection with the DARPA research for which the lyophilizer was used — and the fellow went to Cairo Medical in the early 1980s at a time when Zawahiri was openly recruiting at the Medical School — with subpoena power Grassley could get at where and when the research with virulent Ames was done. The Egyptian scientist and I have a mutual friend who once had been recruited by Ayman Zawahiri to be a member of the Egyptian Islamic Group. And so there are questions relating to distribution of Ames from Ivins’ flask 1029 that need to be addressed, starting with the inventory and shipment records.

    Grassley says FBI needs to report on anthrax investigation
    Saturday, October 28, 2006
    By Stella Shaffe

    http://74.125.47.132/search?q=cache:TW2XS0vHbXMJ:www.radioiowa.com/gestalt/go.cfm%3Fobjectid%3DD76F384D-4D16-4900-A17AB69FC6A7290C+%22Grassley+says+FBI+needs+to+report+on+anthrax+investigation%22&cd=1&hl=en&ct=clnk&gl=us

    Senator Charles Grassley says the FBI’s failed investigation of a 2001 bio-terrorism attack on congress could signal bigger problems.

    Five years ago, a letter laced with a deadly strain of anthrax was sent to the Washington office of Senator Tom Daschle. Grassley says he’s concerned the FBI hasn’t solved the case. But he’s even more unhappy that they refuse to brief congress on the investigation. Grassley sees only one reason for the silence: “If there were some sort of secret thing that was bringing them close to somebody and they didn’t want to let them know they were hot on somebody’s trail.”

    But Grassley says the FBI could make that clear in a report, thereby giving Congress an update and showing they were making progress. Grassley, who is a Republican, says he thinks government should be “transparent” and citizens have a right to know what’s happening particularly when FBI “headquarters is involved and trying to cover up what FBI agents at the grassroots are doing and they’re worried about the public relations of the FBI and that’s when they wind up getting egg on their faces.”

    Grassley charges that the secrecy is proof that the culture of the FBI is not changing like it should be, or as he’s been promised. Grassley’s sent a letter to U.S. Attorney General Alberto Gonzales requesting numerous documents and a full briefing on the anthrax investigation. Grassley, who’s long been a critic of the FBI, says its refusal to submit to congressional oversight has resulted in an inability to prevent crime and terrorism, and has led to misconduct by senior staff members.

    • DXer said

      This is the DARPA-funded research for which Bruce Ivins supplied virulent Ames.

      NANOPARTICLES MAY GET DRAFT NOTICE
      AS MINI SMART BOMBS AGAINST TERROR
      By Tom Henderson
      Small Times Senior Writer
      ANN ARBOR, Mich., Oct. 8, 2001 — A startup company spun off from the University of Michigan (U-M) has created an emulsion it says will help protect civilians and troops from biological terror attacks.

      Ted Annis, chief executive of NanoBio Corp., says its patented antimicrobial substance, a white creamy liquid called NanoProtect, can be applied either before or after an attack to all kinds of surfaces, including skin, clothing and vehicles.

      “Because of the events of Terrible Tuesday, we expect the Department of Defense will come to us with emergency funding to get this to market,” said Annis. “We have been contacted by the Department of Defense and asked to deliver an estimate of the cost and the timing to accelerate the technology.”

      He declined to say which branch of the Defense Department had approached him.

      NanoProtect is the result of a five-year, $11.8 million grant by the U.S. Defense Advanced Projects Research Agency (DARPA) to University of Michigan researcher Dr. James Baker Jr., director of the school’s Center for Biologic Nanotechnology.

      “The nanoemulsion developed by Dr. Baker has had good initial results,” said a DARPA spokesman, adding that it is undergoing further evaluation by the U.S. Army Institute of Surgical Research at Fort Sam Houston in Texas.

      Tests by the Defense Threat Reduction Agency, under the Department of Defense, have shown that the emulsion acts as a decontamination agent.

      NanoBio’s second product, a vaccine that can be sprayed in the nose to provide immunity for chemical and biological agents, is still undergoing university research and is at least two years from the marketplace, said Annis.

      Annis said that so far he has been unable to find a competitor for NanoBio’s biological decontaminants.

      Nanoscale Materials Inc., of Manhattan, Kan., says it will have two nanocrystal products — a skin cream and a spray applied from a fire extinguisher-type canister — on the market in the first quarter of next year that will give protection against chemical agents.

      NanoProtect is a water and oil emulsion, with droplets in the 200- to 400-nanometer range. According to Annis, the size of the droplets’ molecules allows them to bond to and destroy surface membranes of a wide range of agents, including anthrax spores, and the smallpox and Ebola viruses.

      “On a small scale, it sort of blows up the microbe,” said Annis.

      The Sept. 11 terrorist attacks in New York and Washington has changed the company’s market focus from civilian to military applications. Because of DARPA’s role, Annis said, he first approached potential military funding sources a year ago. Funding is needed for further toxicity tests to win approval for use by the U.S. Environmental Protection Agency.

      “But there was no particular timeline we could determine, with the exception of the Army, which planned on rolling out a de-con product in 2006. I knew then that the government was not a marketplace,” he said.

      But since Sept. 11, that has all changed.

      Annis said he expects government funding will accelerate the time to market from at least 18 months to less than a year.

      ***

      NanoBio’s patent covers applications for antiviral, antisporicidal, antifungal and antibacterial applications. Annis said there are about 300 different product formulations, most of which still have to undergo toxicity studies.

      The generally agreed upon qualification of a nanomaterial is 100 nanometers in diameter or smaller. While NanoProtect doesn’t quite qualify, Annis said other products will have eventually have droplets as small as five nanometers.

      Annis said the company will license its technology to pharmaceutical companies and makers of a wide variety of consumer products. “We’re a technology company. We have no plans to manufacture,” he said.

      The company claims its formulations can be used in acne products, mouthwash and toothpaste, as a spermicide, for treatment of herpes 1 and 2, on nonporous kitchen surfaces, in detergents, to purify water, in food processing and in medical labs.

      “It’s a platform technology. There are so many applications, it will keep us busy for a while,” said Annis.

      According to research by Baker’s team at U-M, the emulsions have a shelf life of two years and virtually no toxicity.

  2. DXer said

    Grassley says FBI needs to report on anthrax investigation

    Saturday, October 28, 2006
    By Stella Shaffe

    http://74.125.47.132/search?q=cache:TW2XS0vHbXMJ:www.radioiowa.com/gestalt/go.cfm%3Fobjectid%3DD76F384D-4D16-4900-A17AB69FC6A7290C+%22Grassley+says+FBI+needs+to+report+on+anthrax+investigation%22&cd=1&hl=en&ct=clnk&gl=us

    Senator Charles Grassley says the FBI’s failed investigation of a 2001 bio-terrorism attack on congress could signal bigger problems.

    Five years ago, a letter laced with a deadly strain of anthrax was sent to the Washington office of Senator Tom Daschle. Grassley says he’s concerned the FBI hasn’t solved the case. But he’s even more unhappy that they refuse to brief congress on the investigation. Grassley sees only one reason for the silence: “If there were some sort of secret thing that was bringing them close to somebody and they didn’t want to let them know they were hot on somebody’s trail.”

    But Grassley says the FBI could make that clear in a report, thereby giving Congress an update and showing they were making progress. Grassley, who is a Republican, says he thinks government should be “transparent” and citizens have a right to know what’s happening particularly when FBI “headquarters is involved and trying to cover up what FBI agents at the grassroots are doing and they’re worried about the public relations of the FBI and that’s when they wind up getting egg on their faces.”

    Grassley charges that the secrecy is proof that the culture of the FBI is not changing like it should be, or as he’s been promised. Grassley’s sent a letter to U.S. Attorney General Alberto Gonzales requesting numerous documents and a full briefing on the anthrax investigation. Grassley, who’s long been a critic of the FBI, says its refusal to submit to congressional oversight has resulted in an inability to prevent crime and terrorism, and has led to misconduct by senior staff members.

    http://www.anthraxandalqaeda.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

 
%d bloggers like this: